Updating monitoring strategies and combining them with the latest technology can streamline clinical trial processes to generate higher quality data and increase patient safety, says Brett Wilson.

Sponsors of clinical trials in the United States have a regulatory responsibility under 21 CFR Part 312.50 to monitor the progress of clinical studies. Historically, Sponsors performed in-person ...

This post is sponsored by IMARC Research, Inc. In the realm of clinical research, two functions often work together to complement each other to create an additive impact on the overall quality and ...

Over the last 10 years, clinical trials have changed substantially in response to increasing globalization and study complexity, along with new technological capabilities and industry guidelines 7.

While the policy changes create new opportunities, they also introduce operational complexity. Here's some important things ...

Clinical trials, often one of the most expensive parts of bringing a drug to market, can last as long as a decade. The Covid-19 pandemic has proven clinical trials can be successfully completed in ...

Technology has enabled clinical medicine to adapt remarkably during the COVID-19 pandemic. Through virtual clinic visits, telehealth has allowed clinicians to evaluate and treat patients while ...

The promise of remote patient monitoring is showing itself in more and more telemedicine use cases, with huge potential for day-to-day wellness, management of chronic conditions and the promotion of ...